Project Grant HT9425261E010
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.97M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports the development of CD46-targeted antibody fragment radiopharmaceutical therapy for prostate cancer treatment. This research initiative represents a translational medicine effort to advance diagnostic and...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $328,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2027. The award funds research on intracranial drug delivery strategies targeting skull bone marrow to generate antitumoral myeloid cell immune responses against glioblastoma. This research initiative represents UCSF's...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,594,419 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Radiopathomic Mapping of Tumor Burden for Personalized Management of IDH-Mutant Glioma." The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research focused on developing innovative diagnostic and...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $1.23 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded on September 30, 2025, with a completion date of September 29, 2029. The award supports research to validate CD46 as a promising biomarker in advanced prostate cancer. This research aligns with the program's mission to advance biomedical innovation for...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $1.23 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2029. The grant supports advanced biomedical research investigating the canonical Polycomb repressive complex 1 (CPRC1) as an intrinsic mechanism of resistance to enzalutamide in advanced prostate cancer. This...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $999,999 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2028. The research project focuses on developing cell-free DNA epigenetic biomarkers for multiple sclerosis detection and characterization. This three-year initiative leverages UCSF's established expertise in...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $993,283 Project Grant to The Regents of the University of California, San Francisco under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The award supports research into the proteomic determinants and components of progression in multiple sclerosis. This research initiative aligns with the DHA's mission to transform healthcare for service members...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $2.72 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 15, 2025, through July 14, 2029. The award supports advanced biomedical research titled "Imaging Cardiac Metabolic Flux and Mitochondrial Function by Hyperpolarized 13C and CEST Metabolic Magnetic Resonance Imaging," which will...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco $999,999.00 under the Military Medical Research and Development program (CFDA 12.420) to support the project "Uncovering the Relationship Between Myelin and Synapse Dynamics in Multiple Sclerosis." The award, issued on September 28, 2025, with a completion date of September 27, 2028, funds basic and applied biomedical research aimed at advancing understanding...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,257,982 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded August 1, 2025, with a completion date of July 31, 2028. The project, titled "Mapping the RNA Splicing Landscape of NF1 and Its Impact on Neurofibromin Function Across Tissues," supports advanced biomedical research focused on understanding RNA...
The University of California, San Francisco (UCSF) received a $750,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective March 1, 2026 through February 28, 2029. The award supports research on the use of dimeric immunoglobulin A (dIgA) as a therapeutic approach to treat breast cancer. This three-year research initiative is being conducted at UCSF's San Francisco facility and aligns with the DHA's mission to advance biomedical research addressing critical health challenges relevant to military personnel and the broader public. The grant funds hypothesis-driven research within the DHA's portfolio of cancer immunotherapy and therapeutic development initiatives. As a prominent academic medical center with substantial federal research capabilities, UCSF will deliver research findings and potential therapeutic innovations through this project. The award represents the DHA's investment in translational cancer research aimed at developing novel therapeutic interventions, consistent with the Military Medical Research and Development program's focus on advancing healthcare solutions through basic, applied, and advanced biomedical research across medical domains including oncology.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $750.0k | 2/25/26 |